Home › Cancer (all types) › Ohio
Cancer (all types) clinical trials in Ohio
85 studies for Cancer (all types) are looking for participants at sites in Ohio.
Cities in Ohio
- Columbus40 studies
- Cleveland36 studies
- Cincinnati26 studies
- Akron13 studies
- Dayton7 studies
- Toledo6 studies
- Parma3 studies
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Dayton Physician's Network, Dayton
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 13, 2026 · NCT05920356Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
- Nationwide Children's Hospital, Columbus
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT06423950A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- University Of Cincinnati Medical Center /ID# 251746, Cincinnati
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- OhioHealth O'Bleness Hospital, Athens
- UHHS-Chagrin Highlands Medical Center, Beachwood
- Geauga Hospital, Chardon
- and 26 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- The Ohio State University, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591Pan Tumor Rollover Study
- Oncology Hematology Care, Cincinnati
- The Ohio University, Columbus
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT03899155A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Miami Valley Hospital South, Centerville
- USO - Oncology Hematology Care, Cincinnati
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581Promoting Access, Resources and Treatment Through Novel and Equitable Solutions for Cancer Care
- Case Comprehensive Cancer Center, Cleveland
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06481774Preparing for Life and Academics for Young Childhood Cancer Survivors
- Nationwide Children's Hospital, Columbus
Recruiting
All ages · All sexes · Updated Nov 3, 2026 · NCT06769334Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- Gabrail Cancer & Research Center, Canton
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT05856981Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Oncology Hematology Care, Inc., Cincinnati
- University Hospitals of Cleveland, Cleveland
- Cleveland Clinic Foundation, Cleveland
- and 1 more
RecruitingPhase 2/3
All ages · All sexes · Updated Nov 2, 2026 · NCT03435796A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
- GSK Investigational Site, Columbus
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06796907Visugromab in Cachexia International Trial
- Cleveland Clinic Avon Hospital, Avon
- Cleveland Clinic (Main Campus), Cleveland
- Cleveland Clinic Fairview Hospital, Fairview
- and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07112196Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- The Ohio State University Wexner Medical Center, Columbus
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Oct 30, 2026 · NCT07504458Met Non Small Cell Cancer Registry (MOMENT)
- The Ohio State University Wexner Medical Center, Columbus
RecruitingObservational study
All ages · All sexes · Updated Oct 29, 2026 · NCT05376891A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- University Hospitals - UH Cleveland Medical Center, Cleveland
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07094204Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Nationwide Children's Hospital, Columbus
RecruitingPhase 2
Ages 1 to 26 · All sexes · Updated Oct 28, 2026 · NCT07680439Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Oncology Hematology Care Clinical Trials, LLC, Fairfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07566156Collection of Tissue Samples for Cancer Research
- Ohio State University, Columbus
RecruitingObservational study
2 Months · All sexes · Updated Oct 27, 2026 · NCT00900198Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- The Ohio State University Comprehensive Cancer Center, Columbus
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04981119Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
- Louis Stokes VA Medical Center, Cleveland, OH, Cleveland
Recruiting
Ages 18 and older · All sexes · Updated Oct 23, 2026 · NCT02984761A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- The Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 20, 2026 · NCT07103018A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
- Oncology Hematology Care - Blue Ash /ID# 272918, Cincinnati
- The Ohio State University /ID# 271336, Columbus
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06892522Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 19, 2026 · NCT06162221A Study of ASP3082 in Adults With Advanced Solid Tumors
- Case Western, Cleveland
- Taylor Cancer Research Center, Maumee
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT05382559Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- Miami Valley Hospital South, Centerville
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT05386108Suprachoroidal Administration in Subjects With Metastases to the Choroid
- Cleveland Clinic, Cole Eye Institute, Cleveland
- OH State Wexner Medical Center, Havener Eye Institute, Columbus
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT06643884FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Cleveland
- Cleveland Clinic, Cleveland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 7, 2026 · NCT05919264CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Cleveland Clinic, Cleveland
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT03328078A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 6, 2026 · NCT06979596A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- University of Cincinnati Medical Center. /ID# 278925, Cincinnati
- University Hospitals Cleveland Medical Center /ID# 279601, Cleveland
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 1, 2026 · NCT07024784A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
- University Hospitals Cleveland Medical Center, Cleveland
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07192471uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
- Ohio State University, Columbus
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921Registry Study for Radiation Therapy Outcomes
- University of Cincinnati Medical Center, Cincinnati
RecruitingObservational study
All ages · All sexes · Updated Sep 29, 2026 · NCT01255748A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, Canton
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT06881992A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
- Cincinnati Children's Hospital Medical Center, Cincinnati
Recruiting
Ages 15 to 24 · All sexes · Updated Sep 24, 2026 · NCT07223463A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Oncology Hematology Care - Fairfield /ID# 280641, Fairfield
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Cincinnati Medical Center, Cincinnati
- Kettering Health, Kettering
- West Chester Hospital, West Chester
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Sep 22, 2026 · NCT02693535Statins to Prevent Cancer Associated Blood Clots
- Cleveland Clinic Foundation, Cleveland
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT07303816From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.